https://www.selleckchem.com/pr....oducts/hexamethonium
We also conducted a race/ethnicity-stratified analysis. During follow-up, 10.6% of intervention patients began using MOP vs. 9.3% of controls (p 0.01); the percent of cardiometabolic medication delivered via mail was 42.1% vs. 39.8% (p 0.01). Metformin adherence improved in the intervention arm relative to control at the two KP sites (52% vs. 49%, p 0.01). Stratified analyses suggested a significant positive effect of the intervention in White (RR 1.12, 95% CI 1.03, 1.22) and Asian (RR 1.30, 95% CI 1.17, 1.4